Results 151 to 160 of about 98,685 (336)

Polycystic Kidney Disease Drug Development: A Conference Report

Kidney Medicine, 2023
Autosomal dominant polycystic kidney disease (ADPKD) is part of a spectrum of inherited diseases that also includes autosomal recessive polycystic kidney disease, autosomal dominant polycystic liver disease, and an expanding group of recessively ...
Max C. Liebau, Djalila Mekahli, Ronald Perrone, Belle Soyfer, Sorin Fedeles   +4 more
doaj  

Clinical aspects of polycystic disease of the kidneys. [PDF]

, 1977
H. David Mitcheson, G. Williams, J E Castro   +2 more
openalex   +1 more source

Transitional changes in medication‐initiator cohort profiles in persons with chronic kidney disease and type 2 diabetes—A hospital‐based cohort study in Japan

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To describe temporal changes in the characteristics of medication‐initiator cohorts in persons with chronic kidney disease (CKD) and type 2 diabetes (T2D). Materials and Methods Adults with CKD and T2D initiating sodium‐glucose cotransporter‐2 inhibitors (SGLT‐2i) or glucagon‐like peptide‐1 receptor agonists (GLP‐1RA) were identified in ...
Yuichiro Yano, Suguru Okami, Hiroshi Kanegae, Nikolaus G. Oberprieler, Catherine Johannes, Satoshi Yamashita, Kanae Yoshikawa‐Ryan, Csaba P. Kovesdy, David Vizcaya, Naoki Kashihara   +9 more
wiley   +1 more source

Adult type of polycystic disease of kidneys and liver presenting in childhood [PDF]

, 1974
B. G. Ockenden
openalex   +1 more source

Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non‐diabetic chronic kidney disease

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To evaluate whether type 2 diabetes status modifies the efficacy and safety of combining zibotentan (zibo), a selective endothelin receptor antagonist, and dapagliflozin (dapa) compared to placebo plus dapagliflozin in individuals with chronic kidney disease (CKD).
Victor Wasehuus, J. David Smeijer, Phil Ambery, Peter J. Greasley, Emma Wijkmark, David C. Wheeler, Peter Rossing, Hiddo J. L. Heerspink   +7 more
wiley   +1 more source

Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy. [PDF]

, 2020
Arginine vasopressin (AVP) and its type-2 receptor (V2R) play an essential role in the regulation of salt and water homeostasis by the kidneys. V2R activation also stimulates proliferation of renal cell carcinoma (RCC) cell lines in vitro.
Calvet, James P, Dwivedi, Nidhi, Enders, Jonathan, Jamadar, Abeda, Kakade, Vijayakumar R, Neil, Maura O', Rao, Reena, Sinha, Sonali, Tao, Shixin, Thomas, Sufi M, Weiss, Robert H   +10 more
core  

Management of metabolic dysfunction–associated steatotic liver disease (MASLD)—An expert consensus statement from Indian diabetologists' perspective

Diabetes, Obesity and Metabolism, EarlyView.
Abstract In India, the increasing prevalence of diabetes and obesity poses a significant threat towards a surge in the incidence of metabolic dysfunction‐associated steatotic liver disease (MASLD), formerly known as non‐alcoholic fatty liver disease (NAFLD).
Abdul Hamid Zargar, Anil Bhansali, Anirban Majumdar, Anuj Maheshwari, Arpandev Bhattacharyya, Arundhati Dasgupta, Banshi Damodarlal Saboo, Bipin Kumar Sethi, Debmalya Sanyal, Krishna G. Seshadri, Neeta Rohit Deshpande, Nitin Kapoor, Om Jitendra Lakhani, Pradeep Gopal Talwalkar, Pramila Kalra, Rabindera Nath Mehrotra, Rakesh Kumar Sahay, Rishi Shukla, Saket Kant, Sambit Das, Sanjay Chunilal Agarwal, Sanjeev Ratnakar Phatak, Shanmugasundar G., Shashank Rameshchandra Joshi, Shehla Sajid Shaikh, Sosale Ramachandra Aravind, Soumik Goswami, Sujoy Ghosh, Vijay Kumar Panikar, Viswanathan Mohan   +29 more
wiley   +1 more source

Renal Parenchymal Area and Kidney Collagen Content [PDF]

arXiv, 2016
The extent of renal scarring in chronic kidney disease (CKD) can only be ascertained by highly invasive, painful and sometimes risky tissue biopsy. Interestingly, CKD-related abnormalities in kidney size can often be visualized using ultrasound. Nevertheless, not only does the ellipsoid formula used today underestimate true renal size but also the ...
arxiv  

Prediction of major outcomes in patients with malignant hypertension using machine learning: A report from the West Birmingham malignant hypertension registry

European Journal of Clinical Investigation, EarlyView.
Malignant hypertension (MHT) is a rare, severe condition with high morbidity and mortality. Using data from 385 patients in the West Birmingham MHT Registry, this study evaluated nine machine learning (ML) algorithms to predict a composite outcome of all‐cause mortality/dialysis over a median 11‐year follow‐up.
Antonios A. Argyris, Hironori Ishiguchi, Yang Chen, Yalin Zheng, Alena Shantsila, Eduard Shantsila, D. Gareth Beevers, Gregory Y. H. Lip   +7 more
wiley   +1 more source

Familial orofaciodigital syndrome type I presenting as adult polycystic kidney disease. [PDF]

, 1987
Dian Donnai, L Kerzin-Storrar, R Harris
openalex   +1 more source